$60M sweet spot round size
Most of their 65 investments are in rounds between $36M and $80M
2009
Pharvaris raised $70M on June 20, 2023
Investors: General Atlantic, Foresite Capital and venBio Partners
Undisclosed raised $60M on June 20, 2023
Investors: Illumina Ventures and venBio Partners
Entact Bio raised $81M on December 6, 2022
Investors: Qiming Venture Partners USA, Logos Global Management, LP, Surveyor Capital, Brandon Capital Partners, Abingworth and venBio Partners
FogPharma raised $178M on November 21, 2022
Investors: T. Rowe Price, GV, The Invus Group, Farallon Capital Management and venBio Partners
IMMPACT BIO USA INC raised $111M on January 20, 2022
Investors: RM Global Healthcare Investment Banking & Life Sciences Advisory, Decheng Capital, OrbiMed Advisors, Surveyor Capital, Foresite Capital and venBio Partners
Ceptur Therapeutics raised $75M on January 19, 2022
Investors: Perceptive Advisors, Qiming Venture Partners, LifeSci Venture Partners, Bristol-Myers Squibb, UK, Affinity Asset Advisors and venBio Partners
North Sea group raised $80M on December 17, 2021
Investors: Ysios Capital, -, Hercules Capital, Inc., BGV (BioGeneration Ventures), Forbion, Sofinnova Ventures, Russia technology fund and venBio Partners
HistoWiz raised $32M on October 19, 2021
Investors: Vivo Capital and venBio Partners
CinCor Pharma, Inc. raised $143M on October 12, 2021
Investors: Sixty Degree Capital, Sofinnova Ventures, Russia technology fund, Lilly Asia Ventures, Sofinnova Partners, General Atlantic, Perceptive Advisors, RTW Investments, LP, Omega Funds and venBio Partners
Ventyx Biosciences raised $51M on September 20, 2021
Investors: Third Point LLC, Qiming Venture Partners USA, Surveyor Capital, Vivo Capital, RTW Investments, LP, OrbiMed Advisors, Logos Global Management, LP, Wellington Management and venBio Partners